The Global Bone Marrow Transplantation Market Size accounted for USD 11,108 Million in 2021 and is estimated to garner a market size of USD 18,065 Million by 2030 rising at a CAGR of 5.7% from 2022 to 2030. The increasing number of cancer treatments fuels the bone marrow transplantation market share. Additionally, rising adoption of bone marrow transplantation and growing cases of anemia are also driving the market growth. Rapid technological advancements in these procedure is one of the leading bone marrow transplantation market trends that is fueling the industry share.

Bone Marrow Transplantation Market Report Key Highlights

• Global bone marrow transplantation market revenue is poised to garner USD 18,065 Million by 2030 with a CAGR of 5.7% from 2022 to 2030
• According to CIBMTR 2020 statistics, 4,160 related bone marrow and cord blood transplants were performed in the US
• Europe bone marrow transplantation market will record over 50% regional shares by 2030
• Asia-Pacific bone marrow transplantation market would spur with a substantial CAGR from 2022 to 2030
• Based on type segment, autologous bone marrow transplant accounted more than 60% of the total market share in 2021
• Rising prevalence of blood cancer propels the bone marrow transplantation market value

The method of replacing disease-related or weakened bone marrow or bone marrow stem cells with healthy tissues is often referred to as hematopoietic stem cell transplantation. Bone marrow is soft vascular tissue within long bones that primarily induces the formation of blood cells, lymphocytic growth, and fat accumulation. Severe stages of leukemia, Hodgkin and non-Hodgkin Lymphomas, palatial, sickle cell anemia and thalassemia, etc. are advised for bone marrow transplantation. More than 75.000 bone marrow transplants have been performed worldwide in 2015 and are expected to increase by 25% by the end of 2020. Bone marrow transplantation is known as either peripheral stem cell transplantation (PSCT) or conventional bone marrow transplantation based on the source of the bone marrow or stem cells. High demand for BMOs and continued field work to reduce the risk of negative effects of BMO transplantation can lead to a new market peak for millions of people around the world to improve healthcare.

The report provides analysis of global bone marrow transplantation market for the period 2018 – 2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.

Global Bone Marrow Transplantation Market Dynamics

Market Drivers

• Growing clinical trials for cell therapy
• Growing prevalence of blood cancer across the world
• Increasing number of surgical procedures
• Huge base of elderly population

Market Restraints

• High purchase and procedural cost of bone marrow transplantation devices
• Availability of other therapies

Market Opportunities

• Rapid advancements in drug development
• Expanding base of bone marrow transplant clinics and centers throughout the world

Bone Marrow Transplantations Market Report Coverage

Market	Bone Marrow Transplantation Market
Bone Marrow Transplantation Market Size 2021	USD 11,108 Million
Bone Marrow Transplantation Market Forecast 2030	USD 18,065 Million
Bone Marrow Transplantation Market CAGR During 2022 - 2030	5.7%
Bone Marrow Transplantation Market Analysis Period	2018 - 2030
Bone Marrow Transplantation Market Base Year	2021
Bone Marrow Transplantation Market Forecast Data	2022 - 2030
Segments Covered	By Type, By Indications, By End-User, And By Geography
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	Agendia, Merck Millipore Corporation, Sanofi, AllCells LLC, Diadexus Inc., Abbott, STEMCELL Technologies, Lonza Group Ltd., Conversant Bio, and Qiagen N.V.
Report Coverage	Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Bone Marrow Transplantation Market Insights

The last resort usually prescribed by physicians for bone marrow and blood cancer is bone marrow transplantation. As a result, the spiraling incidence of these diseases, usually blood cancer, may be conveniently projected to be a key force driving the growth of the global bone marrow transplantation industry. Bone marrow dysfunction can be particularly harmful to the health of the human body. In this respect, an increasing need for bone marrow transplantation may be caused by the increasing ubiquity of unhealthy diets, inactive living, and alcohol and nicotine abuse.

There is a move towards climbing on the part of bone marrow transplantation, with patients being more positive about the treatment. Improving the clinical status of patients may be due to intensive study and production of bone marrow transplants. This is expected to greatly improve the success of the global bone marrow transplantation industry as the procedure continues to be unquestionable and technically advanced. Extensive work on the recruitment, processing, and logistical and biological considerations of the donated bone marrow may provide an explanation for increased efficiency.

The improved success rate for bone marrow transplantation for a potential increase in adoption

Patient survival rates following bone marrow transplantation have dramatically improved in recent years, with a significant increase in demand for bone marrow transplantation. Leukemia and other blood cancers could be the safest cure option at the end of the day. For example, FMT in the United States stated that the 1-year survival rate for the Mayo Foundation for Medical Education and Research was 73 percent for BMTs and 98 percent for BMTs in the United States

The increasing prevalence of blood cancer is driving the demand for bone marrow transplantation in emerging regions

The incidence of blood cancer has increased over the last decade. In developing countries, the incidence of blood cancer is 1.5X higher than in developed areas. Increased per capita income has contributed to a significant increase in healthcare spending in most developed regions. The total demand for bone marrow transplantation in the country is expected to increase.

Simple Access to Bone Marrow Care in the United States

Policies such as state bone marrow registries, hematopoietic cell registries for non-profit cells, state marrow donation programs, etc., have made it easy for patients to access the otherwise complicated test cycle in the US. For example, according to a study in the US, the incidence of bone marrow transplantation increased by 5% between 2009 and 2013.

Bone Marrow Transplantation Market Segmentation

The worldwide bone marrow transplantation market is split based on type, indications, end-user, and geography.

Bone Marrow Transplantation Market By Type

• Allogeneic Bone Marrow Transplant
• Autologous Bone Marrow Transplant

According to our bone marrow transplantation industry analysis, autologous bone marrow transplants will hold a significant market share in 2021. Furthermore, autologous bone marrow transplantation is likely to continue in the following years from 2022 to 2030. The first step in this sort of transplant is to extract or harvest the patient's own stem cells. Their stem cells are extracted from their bone marrow or blood and frozen. One benefit of autologous stem cell transplant is that the patient receives his or her own cells.

Bone Marrow Transplantation Market By Indications

• Hodgkin Lymphoma
• Acute Leukaemia
• Multiple Myelomas
• Solid Tumours
• Non-Hodgkin Lymphoma
• Others

According to the bone marrow transplantation market forecast, Hodgkin lymphoma is considered a very prominent indication and will occupy significant shares from 2022 to 2030. In addition to that, acute leukemia is trending in the bone marrow transplant industry due to the increasing number of cases of this indication. Furthermore, solid tumors are likely to record a substantial growth rate during the projected timeframe from 2022 to 2030.

Bone Marrow Transplantation Market By End-User

• Hospitals
• Multispecialty Clinics
• Ambulatory Surgical Centre

As per our findings, the hospitals sub-segment generated the largest market revenue in 2021 and is expected to do so in the coming years. The presence of advanced medical infrastructure, the presence of expert healthcare professionals, and the growing prevalence of cancer and anemia are the factors that are supporting the hospital segment. A bone marrow transplant is indicated to treat advanced stages of blood cancer, sickle cell anemia, and other chronic disorders.

Bone Marrow Transplantation Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Latin America

• Mexico
• Brazil
• Rest of Latin America

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

The Middle East & Africa (MEA)

• Gulf Cooperation Council (GCC)
• South Africa
• Rest of the Middle East & Africa

Introduction to Innovative Healthcare Systems in European Countries Boost the Europe Bone Marrow Transplantation Market

Europe is expected to remain at its highest position as compared to other geographies, accounting for 60% of the global market share. North America is the second largest region followed by Europe. The bone marrow industry would allow the area to thrive on factors such as rising cases of chronic diseases, such as blood cancer, coupled with growing aging populations. Asia-Pacific demand for successful bone marrow transplantation may not be as high as the European and North American industries, which will also become an important medical tourism sector.

Bone Marrow Transplantation Market Players

Some of the top bone marrow transplantation companies offered in the professional report include Agendia, Merck Millipore Corporation, Sanofi, AllCells LLC, Diadexus Inc., Abbott, STEMCELL Technologies, Lonza Group Ltd., Conversant Bio, and Qiagen N.V.

TABLE OF CONTENT